Sarepta Therapeutics Inc. (SRPT)
NASDAQ: SRPT
· Real-Time Price · USD
38.07
-0.72 (-1.86%)
At close: May 23, 2025, 3:59 PM
38.45
1.00%
After-hours: May 23, 2025, 05:53 PM EDT
-1.86% (1D)
| Bid | 37.77 |
| Market Cap | 3.74B |
| Revenue (ttm) | 2.23B |
| Net Income (ttm) | -248.39M |
| EPS (ttm) | -2.64 |
| PE Ratio (ttm) | -14.42 |
| Forward PE | 5.27 |
| Analyst | Buy |
| Ask | 38.45 |
| Volume | 1,710,003 |
| Avg. Volume (20D) | 3,422,690 |
| Open | 38.00 |
| Previous Close | 38.79 |
| Day's Range | 37.64 - 38.41 |
| 52-Week Range | 34.10 - 173.25 |
| Beta | 0.84 |
About SRPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SRPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SRPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 days ago
+0.15%
Sarepta Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
2 weeks ago
-21.45%
Sarepta Therapeutics shares are trading lower after the company reported a Q1 adjusted EPS miss.
2 weeks ago · seekingalpha.com
Sarepta: ELEVIDYS DMD Treatment Setback Brings Downgrade To Hold RatingSarepta Therapeutics, Inc.'s gene therapy SRP-9003 for LGMD 2E/R4 subtype progresses, with potential BLA submission in H2 2025, possibly boosting shareholder value. SRPT rating changed from "Strong Bu...
